| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.02 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.47 | 0.03 |